Infection · 2026
From environmental reservoirs to clinical threats: the expanding resistome and genetic plasticity of Citrobacter spp.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Purkayastha Ankita, Saikia Shyamalima, Gogoi Indrani, Chetia Pankaj
Аннотация
BACKGROUND: Citrobacter spp., a genus of Gram-negative, facultatively anaerobic, non-spore-forming rods, belong to the Enterobacteriaceae family. They are widely distributed in natural environments, including soil, water, and sewage, and are also part of the intestinal flora of humans and animals. These bacteria often act as opportunistic pathogens, posing a severe threat to immunocompromised and the intensive care unit (ICU) patients. Therefore, the rise of multidrug-resistant (MDR) Citrobacter strains represents a rapidly escalating clinical concern.
OBJECTIVE: This review discusses the emergence of MDRCitrobacter spp. and explores the bacterial strategies and mechanisms that contribute to the development and persistence of antimicrobial resistance.
METHODS: A narrative review of the published literature was conducted, focusing on clinical, experimental and surveillance studies that describe antibiotic resistance patterns and mechanisms in Citrobacter spp.
RESULTS: Citrobacter spp. are associated with a range of infections, including urinary tract infections (UTIs), gastrointestinal diseases, neonatal meningitis, and sepsis. Recent reports indicate a growing prevalence of MDR Citrobacter, resistant to multiple antibiotic classes, including some last-resort agents. They utilize β-lactamases production, efflux pump overexpression, target-site modifications, and mobile genetic elements to acquire and spread resistance.
CONCLUSIONS: Citrobacter has evolved as a significant opportunistic pathogen. Extensive investigation into its resistance genes, regulatory pathways and horizontal gene transfer mechanisms is essential for drug development, drug repurposing and generation of alternative therapeutic options to mitigate antibiotic overuse.
OBJECTIVE: This review discusses the emergence of MDRCitrobacter spp. and explores the bacterial strategies and mechanisms that contribute to the development and persistence of antimicrobial resistance.
METHODS: A narrative review of the published literature was conducted, focusing on clinical, experimental and surveillance studies that describe antibiotic resistance patterns and mechanisms in Citrobacter spp.
RESULTS: Citrobacter spp. are associated with a range of infections, including urinary tract infections (UTIs), gastrointestinal diseases, neonatal meningitis, and sepsis. Recent reports indicate a growing prevalence of MDR Citrobacter, resistant to multiple antibiotic classes, including some last-resort agents. They utilize β-lactamases production, efflux pump overexpression, target-site modifications, and mobile genetic elements to acquire and spread resistance.
CONCLUSIONS: Citrobacter has evolved as a significant opportunistic pathogen. Extensive investigation into its resistance genes, regulatory pathways and horizontal gene transfer mechanisms is essential for drug development, drug repurposing and generation of alternative therapeutic options to mitigate antibiotic overuse.